Prostate Cancer - Results from #25520

When to perform bone scan in patients with newly diagnosed prostate cancer: External validation of a novel risk stratification tool - Abstract June 30, 2012

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen - Abstract June 30, 2012

A spotlight from prostate cancer - Abstract June 30, 2012

Prevention and Management of Postprostatectomy Sexual Dysfunctions Part 1: Choosing the right patient at the right time for the right surgery - Abstract June 30, 2012

Elastic image registration for guiding focal laser ablation of prostate cancer: Preliminary results - Abstract June 30, 2012

Morbidity and costs of salvage vs. primary radical prostatectomy in older men - Abstract June 30, 2012

The characteristics of bladder cancer after radiotherapy for prostate cancer - Abstract June 30, 2012

Ultrasound-guided transperineal 24-core saturation prostate biopsy is superior to the 14-core scheme in detecting prostate cancer in patients with PSA less than 20 microg/L - Abstract June 29, 2012

FDA approves new blood test to improve prostate cancer detection June 29, 2012

Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel - Abstract June 29, 2012

Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer - Abstract June 29, 2012

A specific molecular beacon probe for the detection of human prostate cancer cells - Abstract June 29, 2012

The use of photon beams of a flattening filter-free linear accelerator for hypofractionated volumetric modulated arc therapy in localized prostate cancer - Abstract June 29, 2012

A multiphase validation of atlas-based automatic and semiautomatic segmentation strategies for prostate MRI - Abstract June 29, 2012

Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: Lack of impact of primary Gleason pattern on biochemical failure - Abstract June 28, 2012

Millon Behavioral Medicine Diagnostic (MBMD) predicts health-related quality of life (HrQoL) over time among men treated for localized prostate Cancer - Abstract June 28, 2012

Hybrids of a genetically engineered antibody and a carbon nanotube transistor for detection of prostate cancer biomarkers - Abstract June 28, 2012

Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: A population-based analysis - Abstract June 28, 2012

Correlation between cancer location and oncological outcome after radical prostatectomy - Abstract June 28, 2012

The language of prostate cancer treatments and implications for informed decision making by patients - Abstract June 28, 2012

Page 1277 of 1437